Clinical Trials

Multiple Myeloma

NCT02085655 2021-03-15

PEG-ASP+Gemox Regimen and Thalidomide for NK/T Lymphoma

264 enrolled

Lymphoid

Lymphoma, Extranodal NK-T-Cell

NCT04382300 2021-01-28

Pyrotinib Plus Thalidomide in Advanced NSCLC Patients Harboring HER2 Exon 20 Insertions

39 enrolled

Carcinoma, Non-Small-Cell Lung

NCT04612582 2020-11-03

Comparison of BTD and BCD Based Regimens in the Treatment of AL Amyloidosis

70 enrolled

Other hematologic neoplasm

Immunoglobulin Light-chain Amyloidosis

NCT04453345 2020-07-01

TPM Regimen (Thalidomide, Prednisone and Methotrexate) in LGLL

Phase 2/3 Unknown

42 enrolled

Leukemia, Large Granular Lymphocytic

NCT03062800 2019-06-05

Study of Thalidomide in Treatment of Advanced Nsclc (Dream-003)

232 enrolled

Carcinoma, Non-Small-Cell Lung

NCT03777930 2018-12-19

The Evaluation of Curative Effect on Treatment of Tumor Above Thalidomide Combined With Megestrol

200 enrolled

Tumor-Agnostic

Neoplasms, Neoplasms, Second Primary

NCT01554852 2018-06-11

Myeloma XI

4,420 enrolled

Multiple Myeloma, Neoplasms, Plasma Cell

NCT03143036 2018-06-07

Daratumumab, Thalidomide and Dexamethasone in Relapse and/or Refractory Myeloma

100 enrolled

Recurrence, Neoplasms, Plasma Cell

NCT03335098 2017-11-07

BOMB-THROW

15 enrolled

Lymphoid

Waldenstrom Macroglobulinemia, Lymphoma, B-Cell, Marginal Zone

NCT02248428 2017-09-06

CTd

130 enrolled

Multiple Myeloma

NCT03016000 2017-07-28

Thalidomide Maintenance Treatment in DLBCL

226 enrolled

Lymphoid

Lymphoma, Large B-Cell, Diffuse

NCT02778893 2016-05-20

Conmana Combined With Thalidomide to Treat NSCLC

67 enrolled

NSCLC

NCT02748772 2016-04-22

Application of Two Anti-angiogenesis Drugs Combined With Chemotherapy in Advanced Colorectal Cancer Under the Background of Precision Medical

148 enrolled

Colorectal Neoplasms

NCT01551641 2016-02-17

Phase II Trial of Thalidomide Combined With Concurrent Chemoradiotherapy in Esophageal Cancer

180 enrolled

Esophageal Neoplasms

NCT02649101 2016-01-07

Thalidomide Plus Chemotherapy Versus Chemotherapy Alone for Advanced Breast Cancer

60 enrolled

Breast

Breast Neoplasms

NCT02467647 2015-06-10

HLJDT-2016

Phase 1 Unknown

500 enrolled

Multiple Myeloma

NCT02401971 2015-03-30

ITAGC

900 enrolled

Stomach Neoplasms

NCT02387086 2015-03-12

Gefitinib Combined With Thalidomide to Treat NSCLC

Phase 2/3 Unknown

380 enrolled

NSCLC

NCT01924624 2013-08-16

Adjuvant Therapy With Thalidomide After Curative Resection of Hepatocellular Carcinoma

Phase NA Unknown

140 enrolled

Carcinoma, Hepatocellular, Recurrence

NCT01134484 2012-07-20

VELCADE-Thalidomide-Dexamethasone (VTD) vs Thalidomide-Dexamethasone (TD) Incorporated Into Double Autotransplantation for Untreated Multiple Myeloma (MM)

480 enrolled

Pathologic Complete Response, Multiple Myeloma

NCT01114048 2011-09-22

KMM-97

78 enrolled

Multiple Myeloma

NCT00921531 2011-04-19

Adjuvant Therapy With Thalidomide for Chemoembolization in Advanced Hepatocellular Carcinoma

200 enrolled

Carcinoma, Hepatocellular

NCT01249690 2010-11-30

Efficacy Study of PAD and TAD in Newly Diagnosed Multiple Myeloma

100 enrolled

Multiple Myeloma

NCT00124813 2010-02-02

Thalidomide, Cyclophosphamide, Oral Idarubicin and Dexamethasone (T-CID) in Patients With Multiple Myeloma

80 enrolled

Multiple Myeloma

NCT00890188 2009-05-07

UFUR

34 enrolled

Colonic Neoplasms, Colorectal Neoplasms

NCT00349115 2008-05-06

TCD Followed by autoSCT for Newly Diagnosed MM Patients

43 enrolled

Multiple Myeloma

NCT00521482 2007-08-28

Temozolomide vs. Temozolomide and Thalidomide Treatment in Recurrent Glioblastoma

40 enrolled

CNS

Glioblastoma, Recurrence

NCT00319865 2006-04-27

PAD Combination Therapy Followed by Thal/Dex for Relapsed or Refractory Multiple Myeloma

47 enrolled

Multiple Myeloma

NCT00155272 2005-09-12

Radiotherapy Plus Thalidomide in Locally Advanced Hepatocellular Carcinoma

Phase 1/2 Unknown

19 enrolled